Method for the production of high levels of PUFA in plants

US12460221B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12460221-B2
Application numberUS-201917273858-A
CountryUS
Kind codeB2
Filing dateSep 6, 2019
Priority dateSep 7, 2018
Publication dateNov 4, 2025
Grant dateNov 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is concerned with materials and methods for the production of genetically modified plants, particularly where the plants are for the production of at least one unsaturated or polyunsaturated fatty acid. The invention is also concerned with identification of genes conveying an unsaturated fatty acid metabolic property to a plant or plant cell, and generally relates to the field of phosphotidylcholine:diacylglycerol cholinephosphotransferase (PDCT).

First claim

Opening claim text (preview).

The invention claimed is: 1 . A method for increasing the delta-6 elongase conversion efficiency in an oil crop plant of a Brassica species that produces very long chain polyunsaturated fatty acids (vlcPUFAs) and expresses a delta-6 elongase, comprising: providing an oil crop plant of a Brassica species that expresses a delta-6 elongase and a delta-6 desaturase and that has decreased activity, compared to a control plant, of one or more phosphotidylcholine:diacylglycerol cholinephosphotransferase (PDCT) selected from the group consisting of: (a) PDCT3 and/or PDCT5 having at least 80% sequence identity with SEQ ID NO: 18, 20, 22, 24, 26, 28, 30, 32, 50, 52, 54, 56, 58, and/or 60; (b) PDCT3 and/or PDCT5 encoded by a polynucleotide having at least 80% sequence identity with SEQ ID NO: 17, 19, 21, 23, 27, 29, 31, 49, 51, 53, 55, 57 and/or 59; and (c) PDCT3 and/or PDCT5 encoded by a polynucleotide that differs from SEQ ID NO: 17, 19, 21, 23, 27, 29, 31, 49, 51, 53, 55, 57 and/or 59 due to the degeneracy of the genetic code wherein the plant produces docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and docosapentaenoic acid (DPA). 2 . The method of claim 1 , wherein the plant comprises an oil that is characterized by an i. Increased ETA level ii. Reduced ALA level, iii. Reduced GLA level iv. Reduced SDA level, v. The level of the 18:2 fatty acid fraction in % (w/w) in the triacylglycerol (TAG) composition is higher than the 18:2 fatty acid level in % (w/w) in the diacylglyerol (DAG) fraction, vi. The level of the 20:0 fatty acid in % (w/w) in the diacylglyerol fraction is higher than the 20:0 fatty acid level in % (w/w) in the triacylglycerol fraction vii. The level of the 22:1 fatty acid in % (w/w) in the diacylglyerol (DAG) fraction is higher than the 22:1 level in % (w/w) in the triacylglycerol fraction and/or viii. Reduced 18:1 fatty acid level; compared to a control, and, optionally, comprising the further step of isolating the oil from the plant or a part thereof, the plant cell, and/or the plant seed. 3 . The method of claim 1 , wherein the plant is a B. napus plant, and wherein the plant has decreased activity of one or more PDCT selected from the group consisting of: (a) a PDCT3 having at least 90% sequence identity with SEQ ID NO: 18 or 22 or 24; (b) a PDCT5 having at least 90% sequence identity with SEQ ID NO: 20 or 26 or 28; (c) a PDCT3 encoded by a polynucleotide having at least 90% sequence identity with SEQ ID NO: 17 or 21 or 23; (d) a PDCT5 encoded by a polynucleotide having at least 90% sequence identity with SEQ ID NO: 19 or 25 or 27; (e) a PDCT3 encoded by a polynucleotide that differs from SEQ ID NO: 17 or 21 or 23 due to the degeneracy of the genetic code; and (f) a PDCT5 encoded by a polynucleotide that differs from SEQ ID NO: 19 or 25 or 27 due to the degeneracy of the genetic code. 4 . The method of claim 1 , wherein the plant is a B. carinata plant, and wherein the plant has decreased activity of one or more PDCT selected from the group consisting of: (e) a PDCT3 having at least 90% sequence identity with SEQ ID NO: 18 or 22 or 24; (f) a PDCT5 having at least 90% sequence identity with SEQ ID NO: 20 or 26 or 28; (g) a PDCT3 encoded by a polynucleotide having at least 90% sequence identity with SEQ ID NO: 17 or 21 or 23; (h) a PDCT5 encoded by a polynucleotide having at least 90% sequence identity with SEQ ID NO: 19 or 25 or 27; (i) a PDCT3 encoded by a polynucleotide that differs from SEQ ID NO: 17 or 21 or 23 due to the degeneracy of the genetic code; and (j) a PDCT5 encoded by a polynucleotide that differs from SEQ ID NO: 19 or 25 or 27 due to the degeneracy of the genetic code. 5 . The method of claim 1 , wherein the plant is a B. juncea plant, and wherein the plant has decreased activity of one or more PDCT selected from the group consisting of: (a) PDCT3 and/or PDCT5 having at least 80% sequence identity with SEQ ID NO: 18, 20, 22, 24, 26, 28, 30, 32, 50, 52, 54, 56, 58, and/or 60; (b) PDCT3 and/or PDCT5 encoded by a polynucleotide having at least 80% sequence identity with SEQ ID NO: 17, 19, 21, 23, 27, 29, 31, 49, 51, 53, 55, 57 and/or 59; and (c) PDCT3 and/or PDCT5 encoded by a polynucleotide that differs from SEQ ID NO: 17, 19, 21, 23, 27, 29, 31, 49, 51, 53, 55, 57 and/or 59 due to the degeneracy of the genetic code.

Assignees

Inventors

Classifications

  • Diacylglycerol cholinephosphotransferase (2.7.8.2) · CPC title

  • Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

  • Transferases for other substituted phosphate groups (2.7.8) · CPC title

  • against enzymes · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12460221B2 cover?
The present invention is concerned with materials and methods for the production of genetically modified plants, particularly where the plants are for the production of at least one unsaturated or polyunsaturated fatty acid. The invention is also concerned with identification of genes conveying an unsaturated fatty acid metabolic property to a plant or plant cell, and generally relates to the f…
Who is the assignee on this patent?
Basf Plant Science Co Gmbh
What technology area does this patent fall under?
Primary CPC classification C12N15/8247. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).